CD38 gene polymorphism and risk of chronic lymphocytic leukemia

Leukemia Research

Volumn 36, Issue 10, 2012, Pages 1237-1240

  Abramenko, Iryna V ^a   Bilous, Nadiia I ^a   Pleskach, Gleb V ^a   Chumak, Anatoliy A ^a   Kryachok, Iryna A ^b   Martina, Zoya V ^a   Dyagil, Iryna S ^a  

^a STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

^b NATIONAL CANCER INSTITUTE   (Ukraine)

Author keywords

CD38 rs6449182 polymorphism; Chronic lymphocytic leukemia; Genetic susceptibility

Indexed keywords

CD38 ANTIGEN; GENOMIC DNA; LIPID;

ADULT; AGED; ARTICLE; CANCER RISK; CD38 GENE; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENE REARRANGEMENT; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN VARIABLE GENE; LEUKEMOGENESIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; UKRAINE;

ANTIGENS, CD38; CASE-CONTROL STUDIES; DNA; FEMALE; GENOTYPE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84865161658     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.05.014     Document Type: Article

References (25)

1. Venugopal P., Gregory S.A. Lymphoproliferative disorders. ASH-SAP American Society of Hematology self-assessment program 2007, 265-300. American Society of Hematology, Washington. 3rd ed. M.J. Kahn, S.A. Gregory (Eds.).
2. Sherborne A.L., Houlston R.S. What are genome-wide association studies telling us about B-cell tumor development?. Oncotarget 2010, 1:367-377.
3. Crowther-Swanepoel D., Broderick P., Di Bernardo M.C., Dobbins S.E., Torres M., Mansouri M., et al. Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat Genet 2010, 42:132-159.
4. Malavasi F., Deaglio S., Damle R., Curtona G., Ferrarini M., Chiorazzi N. CD38 and chronic lymphocytic leukemia: a decade later. Blood 2011, 118:3470-3478.
5. Ferrero E., Saccucci F., Malavasi F. The human CD38 gene: polymorphism, CpG island, and linkage to the CD157 (BST-1) gene. Immunogenetics 1999, 49:597-604.
6. Jamroziak K., Szemraj Z., Grzybowska-Izydorczyk O., Szemraj J., Bieniasz M., Cebula B., et al. CD38 gene polymorphisms contribute to genetic susceptibility to B-cell chronic lymphocytic leukemia: evidence from two case-control studies in Polish Caucasians. Cancer Epidemiol Biomarkers Prev 2009, 18:945-953.
7. Aydin S., Rossi D., Bergui L., D'Arena G., Ferrero E., Bonello L., et al. CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?. Blood 2008, 111:5646-5653.
8. Binet J.L., Auguier A., Dighiero G., Chastang C., Piguet H., Goasguen J., et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981, 48:198-205.
9. Rai K.R., Sawitzky A., Cronkite E.P., Chanana A.D., Levy R.N., Pasternack B.S. Clinical staging of chronic lymphocytic leukemia. Blood 1975, 46:219-234.
10. Abramenko I., Bilous N., Chumak A., Davidova E., Kryachok I., Martina Z., et al. Chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chernobyl NPP accident-with focus on immunoglobulin heavy chain gene analysis. Leuk Res 2008, 32:535-545.
11. Gonzalez-Escribano M.F., Aguilar F., Torres B., Sanchez-Roman J., Nunez-Roldan A. CD38 polymorphisms in Spanish patients with systemic lupus erythematosus. Hum Immunol 2004, 65:660-664.
12. Drummond F.J., Mackrill J.J., O'Sullivan K., Daly M., Shanahan F., Molloy M.G. CD38 is associated with premenopausal and postmenopausal bone mineral density and postmenopausal bone loss. J Bone Miner Metab 2006, 24:28-35.
13. Deaglio S., Vaisitti T., Serra S., Audrito V., Bologna C., D'Arena G., et al. CD38 in chronic lymphocytic leukemia: from bench to bedside?. Mini Rev Med Chem 2011, 11:503-507.
14. Deaglio S., Vaisitti T., Zucchetto A., Gattei V., Malavasi F. CD38 as a molecular compass guiding topographical decisions of chronic lymphocytic leukemia cells. Semin Cancer Biol 2010, 20:416-423.
15. Damle R.N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S.L., et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999, 94:1840-1847.
16. Saborit-Villarroya I., Vaisitti T., Rossi D., D'Arena G., Gaidano G., Malavasi F., et al. E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia. Leukemia 2011, 25:479-488.
17. Qiu J., Cheng R., Zhou X.Y., Zhu J.G., Zhu C., Qin D.N., et al. Gene expression profiles of adipose tissue of high-fat diet-induced obese rats by cDNA microarrays. Mol Biol Rep 2010, 37:3691-3695.
18. Barbosa M.T., Soares S.M., Novak C.M., Sinclair D., Levine J.A., Aksoy P., et al. The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity. FASEB J 2007, 21:3629-3639.
19. Cai G., Cole S.A., Freeland-Graves J.H., MacCluer J.W., Blangero J., Comuzzie A.G. Principal component for metabolic syndrome risk maps to chromosome 4p in Mexican Americans: the San Antonio Family Heart Study. Hum Biol 2004, 76:651-665.
20. Lorenc J., Kozak-Michalowska I., Polkowska-Kulesza E. Disorders of lipid and lipoprotein metabolism in patients with chronic lymphocytic leukemia. I. Preliminary evaluation of lipemia and HDL fractions in various stages of the disease. Przegl Lek 1989, 46:713-718.
21. Shanafelt T.D., Bowen D., Venkat C., Slager S.L., Zent C.S., Kay N.E., et al. Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients. Br J Haematol 2007, 139:255-264.
22. Lanemo Myhrinder A., Hellqvist E., Sidorova E., Soderberg A., Baxendale H., Dahle C., et al. A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood 2008, 111:3838-3848.
23. Catera R., Silverman G.J., Hatzi K., Seiler T., Didier S., Zhang L., et al. Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation. Mol Med 2008, 14:665-674.
24. Rosen A., Murray F., Evaldsson C., Rosenquist R. Antigens in chronic lymphocytic leukemia-implications for cell origin and leukemogenesis. Semin Cancer Biol 2010, 20:400-409.
25. Chiorazzi N., Ferrarini M. Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood 2011, 111:1781-1791.